These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3071053)

  • 1. [Hormonal contraceptives and cardiovascular risk. Results of an East German multicenter case control study].
    Meinel H; Göretzlehner G; Heinemann L
    Zentralbl Gynakol; 1988; 110(23):1507-14. PubMed ID: 3071053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of hormonal contraceptives for coronary heart disease].
    Gohlke-Bärwolf C
    Herz; 1987 Aug; 12(4):263-75. PubMed ID: 3308662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive use and cardiovascular disease: is the relationship real or due to study bias?
    Katerndahl DA; Realini JP; Cohen PA
    J Fam Pract; 1992 Aug; 35(2):147-57. PubMed ID: 1386621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1998; 877():i-vii, 1-89. PubMed ID: 9615606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk of oral contraceptives. Low, and mainly in women at risk.
    Prescrire Int; 1998 Aug; 7(36):118-24. PubMed ID: 10342951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral contraceptives: cardiovascular complications and additional risk factors (author's transl)].
    Herzog C
    Schweiz Rundsch Med Prax; 1979 Oct; 68(41):1321-9. PubMed ID: 394143
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oral contraceptives and cardiovascular diseases morbidity].
    Lara Ricalde R; Aznar Ramos R
    Ginecol Obstet Mex; 1986 May; 54():119-25. PubMed ID: 3732840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and nonfatal vascular disease--recent experience.
    Porter JB; Hunter JR; Danielson DA; Jick H; Stergachis A
    Obstet Gynecol; 1982 Mar; 59(3):299-302. PubMed ID: 7078875
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hormonal contraceptive agents as a risk factor in the development of acute thromboembolic diseases].
    Lambrekht R; Vageman V; Vinkelman B; Geĭnrikh P
    Khirurgiia (Mosk); 1986 Dec; (12):90-3. PubMed ID: 3821001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal contraceptive methods.
    McEwan J
    Practitioner; 1985 May; 229(1403):415-23. PubMed ID: 4011568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined contraceptives and cardiovascular risk].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic effects of oral contraceptives.
    Kelly TM
    West J Med; 1984 Jul; 141(1):113-6. PubMed ID: 6089441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
    Tanis BC; Rosendaal FR
    Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular issues with oral contraceptives: evidenced-based medicine.
    Burkman RT
    Int J Fertil Womens Med; 2000; 45(2):166-74. PubMed ID: 10831186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Third generation P-pills and deep venous thrombosis].
    Olsen J
    Ugeskr Laeger; 1996 Mar; 158(13):1843-5. PubMed ID: 8650762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease and use of oral contraceptives. WHO Collaborative Study.
    Bull World Health Organ; 1989; 67(4):417-23. PubMed ID: 2805219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.